C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis

References

• Rahman A., Isenberg d. A.. Systemic lupus erythematosus. N. Engl. J. Med.. 2008; 358:929–939.
   PubMed Web of Science ®Google Scholar
• Moroni G., Radice A., Giammarresi G., . Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis. Ann. Rheum. Dis.. 2009; 68:234–237.
   PubMed Web of Science ®Google Scholar
• Akhter E., Burlingame R. W., Seaman A. L., Magder L., Petri M.. Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers. Lupus. 2011; 20:1267–1274.
   PubMed Web of Science ®Google Scholar
• Matrat A., Veysseyre-Balter C., Trolliet P., . Simultaneous detection of anti-C1q and anti-double stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares. Lupus. 2011; 20:28–34.
   PubMed Web of Science ®Google Scholar
• Alonso M. D., Llorca J., Martinez-Vazquez F., . Systemic lupus erythematosus in northwestern Spain: a 20-year epidemiologic study. Medicine (Baltimore). 2011; 90:350–358.
   PubMed Web of Science ®Google Scholar
• Bertsias G. K., Salmon J. E., Boumpas D. T.. Therapeutic opportunities in systemic lupus erythematosus: state of the art and prospects for the new decade. Ann. Rheum. Dis.. 2010; 69:1603–1611.
   PubMedGoogle Scholar
• Radic M., Herrmann M., van der Vlag J., Rekvig O. P.. Regulatory and pathogenetic mechanisms of autoantibodies in SLE. Autoimmunity. 2011; 44:349–356.
   PubMed Web of Science ®Google Scholar
• O'Flynn J., Flierman R., van der Pol P., . Nucleosomes and C1q bound to glomerular endothelial cells serve as targets for autoantibodies and determine complement activation. Mol. Immunol.. 2011; 49:75–83.
   Google Scholar
• Mannik M., Merrill C. E., Stamps L. D., Wener M. H.. Multiple autoantibodies form the glomerular immune deposits in patients with systemic lupus erythematosus. J. Rheumatol.. 2003; 30:1495–1504.
   PubMed Web of Science ®Google Scholar
• Ravetch J.. In vivo veritas: the surprising roles of Fc receptors in immunity. Nat. Immunol.. 2010; 11:183–185.
   Google Scholar
• Kruse K., Janko C., Urbonaviciute V., . Inefficient clearance of dying cells in patients with SLE: anti-dsDNA autoantibodies, MFG-E8, HMGB-1 and other players. Apoptosis. 2000; 15:1098–1113.
   Google Scholar
• Tincani A., Spatola L., Prati E., . The anti-beta2-glycoprotein I activity in human anti-phospholipid syndrome sera is due to monoreactive low-affinity autoantibodies directed to epitopes located on native beta2-glycoprotein I and preserved during species' evolution. J. Immunol.. 1996; 157:5732–5738.
   PubMedGoogle Scholar
• Agrawal A., Singh P. P., Bottazzi B., Garlanda C., Mantovani A.. Pattern recognition by pentraxins. Adv. Exp. Med. Biol.. 2009; 653:98–116.
   PubMed Web of Science ®Google Scholar
• Truedsson L., Bengtsson A. A., Sturfelt G.. Complement deficiencies and systemic lupus erythematosus. Autoimmunity. 2007; 40:560–566.
   PubMed Web of Science ®Google Scholar
• Lech M., Römmele C., Kulkarni O. P., . Lack of the long pentraxin PTX3 promotes autoimmune lung disease but not glomerulonephritis in murine systemic lupus erythematosus. PLoS One. 2011; 6:e20118.
   PubMed Web of Science ®Google Scholar
• Bickerstaff M. C., Botto M., Hutchinson W. L., . Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat. Med.. 1999; 5:694–697.
   PubMed Web of Science ®Google Scholar
• Russell A. I., Cunninghame Graham D. S., Shepherd C., . Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum. Mol. Genet.. 2004; 13:137–147.
   PubMed Web of Science ®Google Scholar
• Rodriguez W., Mold C., Marnell L. L., . Prevention and reversal of nephritis in MRL/lpr mice with a single injection of C-reactive protein. Arthritis Rheum. 2006; 54:325–335.
   PubMed Web of Science ®Google Scholar
• Szalai A. J., Weaver C. T., McCrory M. A., . Delayed lupus onset in (NZB x NZW)F1 mice expressing a human C-reactive protein transgene. Arthritis Rheum.. 2003; 48:1602–1611.
   PubMedGoogle Scholar
• Jönsen A., Gullstrand B., Güner N., . Genetically determined mannan-binding lectin deficiency is of minor importance in determining susceptibility to severe infections and vascular organ damage in systemic lupus erythematosus. Lupus. 2007; 16:245–253.
   PubMedGoogle Scholar
• Carlucci F., Cook H. T., Garg A., Pepys M. B., Botto M.. Lack of effect of a single injection of human C-reactive protein on murine lupus or nephrotoxic nephritis. Arthritis Rheum.. 2010; 62:245–249.
   Google Scholar
• Sjöwall C., Wetterö J.. Pathogenic implications for autoantibodies against C-reactive protein and other acute phase proteins. Clin. Chim. Acta. 2007; 378:13–23.
   PubMed Web of Science ®Google Scholar
• O'Neill S. G., Giles I., Lambrianides A., . Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus. Arthritis Rheum.. 2010; 62:845–854.
   PubMed Web of Science ®Google Scholar
• Shoenfeld Y., Szyper-Kravitz M., Witte T., . Autoantibodies against protective molecules – C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus. Ann. NY Acad. Sci.. 2007; 1108:227–239.
   PubMed Web of Science ®Google Scholar
• Lakota K., Zigon P., Mrak-Poljsak K., . Antibodies against acute phase proteins and their functions in the pathogenesis of disease: a collective profile of 25 different antibodies. Autoimmun. Rev.. 2011; 10:779–789.
   PubMedGoogle Scholar
• Lakota K., Thallinger G. G., Cucnik S., . Could antibodies against serum amyloid A function as a physiological regulators in humans?. Autoimmunity. 2011; 44:149–158.
   PubMed Web of Science ®Google Scholar
• Sjöwall C., Bengtsson A. A., Sturfelt G., Skogh T.. Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus. Arthritis Res. Ther.. 2004; 6:R87–R94.
   PubMed Web of Science ®Google Scholar
• Sjöwall C., Zickert A., Skogh T., Wetterö J., Gunnarsson I.. Serum levels of autoantibodies against C-reactive protein correlate with renal disease activity and response to therapy in lupus nephritis. Arthritis Res. Ther.. 2009; 11:R188.
   Google Scholar
• Diehl E. E., Haines G. K.3rd, Radosevich J. A., Potempa L. A.. Immunohistochemical localization of modified C-reactive protein antigen in normal vascular tissue. Am. J. Med.. 2000; 319:79–83.
   Google Scholar
• Rees R. F., Gewurz H., Siegel J. N., Coon J., Potempa L. A.. Expression of a C-reactive protein neoantigen (neo-CRP) in inflamed rabbit liver and muscle. Clin. Immunol. Immunopathol.. 1988; 48:95–107.
   PubMedGoogle Scholar
• Schwedler S. B., Guderian F., Dammrich J., Potempa L. A., Wanner C.. Tubular staining of modified C-reactive protein in diabetic chronic kidney disease. Nephrol. Dial Transplant.. 2003; 18:2300–2307.
   Google Scholar
• Jabs W. J., Logering B. A., Gerke P., . The kidney as a second site of human C-reactive protein formation in vivo. Eur. J. Immunol.. 2003; 33:152–161.
   Google Scholar
• Bíró A., Rovó Z., Papp D., . Studies on the interactions between C-reactive protein and complement proteins. Immunology. 2007; 121:40–50.
   PubMed Web of Science ®Google Scholar
• Sjöwall C., Wetterö J., Bengtsson T., . Solid-phase classical complement activation by C-reactive protein (CRP) is inhibited by fluid-phase CRP-C1q interaction. Biochem. Biophys. Res. Commun.. 2007; 352:251–258.
   PubMed Web of Science ®Google Scholar
• Mihlan M., Blom A. M., Kupreishvili K., . Monomeric C-reactive protein modulates classic complement activation on necrotic cells. FASEB J.. 2011; 25:4198–4210.
   PubMed Web of Science ®Google Scholar
• Nakahara C., Kanemoto K., Saito N., . C-reactive protein frequently localizes in the kidney in glomerular diseases. Clin. Nephrol.. 2001; 55:365–370.
   Google Scholar
• Zuniga R., Markowitz G. S., Arkachaisri T., . Identification of IgG subclasses and C-reactive protein in lupus nephritis: the relationship between the composition of immune deposits and Fc gamma receptor type IIA alleles. Arthritis Rheum.. 2003; 48:460–470.
   PubMedGoogle Scholar
• Tan E. M., Cohen A. S., Fries J. F., . The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum.. 1982; 25:1271–1277.
   PubMed Web of Science ®Google Scholar
• Gladman D. D., Ibañez D., Urowitz M.. Systemic lupus erythematosus disease activity index 2000. J. Rheumatol.. 2000; 29:288–291.
   Web of Science ®Google Scholar
• Gladman D., Ginzler E., Goldsmith C., . The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum.. 1996; 39:363–369.
   PubMed Web of Science ®Google Scholar
• Mills J. A., Michel B. A., Bloch D. A., . The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum.. 1990; 33:1114–1121.
   PubMed Web of Science ®Google Scholar
• Weening J. J., D'Agati V. D., Schwartz M. M., . The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int.. 2004; 65:521–530.
   PubMed Web of Science ®Google Scholar
• Philimonenko A. A., Janácek J., Hozák P.. Statistical evaluation of co-localization patterns in immunogold labeling experiments. J. Struct. Biol.. 2000; 132:201–210.
   PubMed Web of Science ®Google Scholar
• Kalaaji M., Mortensen E., Jørgensen L., Olsen R., Rekvig O. P.. Nephritogenic lupus antibodies recognize glomerular basement membrane-associated chromatin fragments released from apoptotic intraglomerular cells. Am. J. Pathol.. 2006; 168:1779–1792.
   PubMed Web of Science ®Google Scholar
• Shrive A. K., Cheetham G. M., Holden D., Nat. Struct. Biol.. 1996; 3:346–354.
   PubMedGoogle Scholar
• Wolbink G. J., Brouwer M. C., Buysmann S., ten Berge I. J., Hack C. E.. CRP-mediated activation of complement in vivo: assessment by measuring circulating complement–C-reactive protein complexes. J. Immunol.. 1996; 157:473–479.
   PubMed Web of Science ®Google Scholar
• Meuwissen M., van der Wal A. C., Niessen H. w., . Colocalisation of intraplaque C-reactive protein, complement, oxidised low density lipoprotein, and macrophages in stable and unstable angina and acute myocardial infarction. J. Clin. Pathol.. 2006; 59:196–201.
   Google Scholar
• Mårtensson U., Sjöholm A. G., Sturfelt G., Truedsson L., Laurell A. B.. Western blot analysis of human IgG reactive with the collagenous portion of C1q: evidence of distinct binding specificities. Scand. J. Immunol.. 1992; 35:735–744.
   Google Scholar
• Maire M. A., Barnet M., Carpentier N., Miescher P. A., Lambert P. H.. Identification of components of IC purified from human sera: I. Immune complexes purified from sera of patients with SLE. Clin. Ex.p Immunol.. 1983; 51:215–224.
   Google Scholar
• Fismen S., Hedberg A., Fenton K. A., . Circulating chromatin-anti-chromatin antibody complexes bind with high affinity to dermo-epidermal structures in murine and human lupus nephritis. Lupus. 2009; 18:597–607.
   Google Scholar
• Suresh M. V., Singh S. K., Agrawal A.. Interaction of calcium-bound C-reactive protein with fibronectin is controlled by pH: in vivo implications. J. Biol. Chem.. 2004; 279:52552–52557.
   PubMed Web of Science ®Google Scholar
• Hedberg A., Mortensen E. S., Rekvig O. P.. Chromatin as a target antigen in human and murine lupus nephritis. Arthritis Res. Ther.. 2011; 13:214.
   PubMed Web of Science ®Google Scholar
• Janko C., Franz S., Muñoz L. E., . CRP/anti-CRP antibodies assembly on the surfaces of cell remnants switches their phagocytic clearance toward inflammation. Front. Immunol.. 2011; 2:70.
   PubMed Web of Science ®Google Scholar
• Yang X. W., Tan Y., Yu F., Zhao M. H.. Interference of antimodified C-reactive protein autoantibodies from lupus nephritis in the biofunctions of modified C-reactive protein. Hum. Immunol.. 2012; 73:156–163.
   PubMed Web of Science ®Google Scholar
• Schaller M., Bigler C., Danner D., Ditzel H. J., Trendelenburg M.. Autoantibodies against C1q in systemic lupus erythematosus are antigen-driven. J Immunol. 2009; 183:8225–8231.
   Google Scholar
• Radanova M., Vasilev V., Deliyska B., . Anti-C1q autoantibodies specific against the globular domain of the C1qB-chain from patient with lupus nephritis inhibit C1q binding to IgG and CRP. Immunobiology. 2012; 217:684–691.
   Google Scholar
• Skogh T., Stendahl O.. Complement-mediated delay in immune complex clearance from the blood owing to reduced deposition outside the reticuloendothelial system. Immunology. 1983; 49:53–59.
   Google Scholar
• Skogh T., Blomhoff R., Eskild W., Berg T.. Hepatic uptake of circulating IgG immune complexes. Immunology. 1985; 55:585–594.
   PubMed Web of Science ®Google Scholar